These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35535794)

  • 1. Evidence of Clinical Impact Supports a New Petition for Medicare Coverage of 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in the Evaluation of Staphylococcus aureus Bacteremia: A Focused Literature Review and Call to Action.
    Thottacherry E; Cortés-Penfield NW
    Clin Infect Dis; 2022 Oct; 75(8):1457-1461. PubMed ID: 35535794
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
    J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Berrevoets MAH; Kouijzer IJE; Aarntzen EHJG; Janssen MJR; De Geus-Oei LF; Wertheim HFL; Kullberg BJ; Oever JT; Oyen WJG; Bleeker-Rovers CP
    J Nucl Med; 2017 Sep; 58(9):1504-1510. PubMed ID: 28336786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F]FDG-PET/CT in Staphylococcus aureus bacteremia: a systematic review.
    Buis DTP; Sieswerda E; Kouijzer IJE; Huynh WY; Burchell GL; Berrevoets MAH; Prins JM; Sigaloff KCE
    BMC Infect Dis; 2022 Mar; 22(1):282. PubMed ID: 35331165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias.
    van der Vaart TW; Prins JM; van Werkhoven CH; Ten Doesschate T; Soetekouw R; van Twillert G; Veenstra J; Herpers BL; Rozemeijer W; Jansen RR; Bonten MJM; van der Meer JTM
    Clin Infect Dis; 2023 Jul; 77(1):9-15. PubMed ID: 36869816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus.
    Brøndserud MB; Pedersen C; Rosenvinge FS; Høilund-Carlsen PF; Hess S
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1351-1358. PubMed ID: 30788532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of
    Suanzes P; Willekens R; Puig-Asensio M; Pizzi MN; Roque A; Barios M; Simó M; Rodríguez-Pardo D; Larrosa MN; Fernández-Hidalgo N; Almirante B
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Jan; 41(1):3-10. PubMed ID: 36319538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of FDG-PET/CT in the Diagnostic Workup for Staphylococcus aureus Bacteremia: A Prospective Interventional Matched-cohort Study.
    Ghanem-Zoubi N; Kagna O; Abu-Elhija J; Mustafa-Hellou M; Qasum M; Keidar Z; Paul M
    Clin Infect Dis; 2021 Dec; 73(11):e3859-e3866. PubMed ID: 32639560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of infectious foci on FDG PET/CT in Staphylococcus aureus bacteremia.
    Ghanem-Zoubi N; Abu-Elhija J; Kagna O; Mustafa-Hellou M; Qasum M; Haber D; Paul M; Keidar Z
    Sci Rep; 2023 Aug; 13(1):14063. PubMed ID: 37640802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging in the investigation and management of Staphylococcus aureus bacteraemia: a role for advanced imaging techniques.
    Goodman AL; Cook GJ; Goh V
    J Hosp Infect; 2020 Jun; 105(2):234-241. PubMed ID: 31953235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia.
    Vos FJ; Kullberg BJ; Sturm PD; Krabbe PFM; van Dijk APJ; Wanten GJA; Oyen WJG; Bleeker-Rovers CP
    Medicine (Baltimore); 2012 Mar; 91(2):86-94. PubMed ID: 22391470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia.
    Vos FJ; Bleeker-Rovers CP; Sturm PD; Krabbe PF; van Dijk AP; Cuijpers ML; Adang EM; Wanten GJ; Kullberg BJ; Oyen WJ
    J Nucl Med; 2010 Aug; 51(8):1234-40. PubMed ID: 20660384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualizing the use of [
    van Leerdam EJ; Gompelman M; Tuinte RAM; Aarntzen EHJG; Berrevoets MAH; Maat I; Bleeker-Rovers CP; van Crevel R; Ten Oever J; Kouijzer IJE
    Infection; 2022 Apr; 50(2):491-498. PubMed ID: 34928493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Staphylococcus aureus Bacteremia: Do We Already Know Enough?
    Buis DTP; Prins JM; Sigaloff KCE
    Clin Infect Dis; 2022 Nov; 75(10):1867. PubMed ID: 35788649
    [No Abstract]   [Full Text] [Related]  

  • 15. Septic pulmonary emboli detected by
    Méndez-Echevarria A; Coronado-Poggio M; Baquero-Artigao F; Del Rosal T; Rodado-Marina S; Calvo C; Domínguez-Gadea L
    Infection; 2017 Oct; 45(5):691-696. PubMed ID: 28243995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light in the dark:
    Colombo J; Elzi L; Treglia G; Perren A
    Intensive Care Med; 2018 Apr; 44(4):488-489. PubMed ID: 29134234
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia.
    Pijl JP; Kwee TC; Slart RHJA; Yakar D; Wouthuyzen-Bakker M; Glaudemans AWJM
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1467-1477. PubMed ID: 33106925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography in rheumatological diseases.
    Subesinghe M; Bhuva S; Arumalla N; Cope A; D'Cruz D; Subesinghe S
    Rheumatology (Oxford); 2022 May; 61(5):1769-1782. PubMed ID: 34463703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of [
    Gompelman M; Tuinte R; Aarntzen E; Kouijzer I; van Leerdam E; Berrevoets M; Ten Oever J; Bleeker-Rovers C; Wanten G
    Biomed Pharmacother; 2021 Dec; 144():112296. PubMed ID: 34634557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in patients with high risk Staphylococcus aureus bacteremia undergoing or not PET-CT: A single center experience.
    Yildiz H; Reychler G; Rodriguez-Villalobos H; Orioli L; D'Abadie P; Vandeleene B; Danse E; Vandercam B; Pasquet A; Yombi JC
    J Infect Chemother; 2019 Nov; 25(11):880-885. PubMed ID: 31105001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.